Cargando…

Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model

OBJECTIVE: Given the major shift to patient-directed education, novel coronavirus (nCoV) provides a live example on how medicinal chemistry could be a key science to teach pharmacy students. In this paper, students and clinical pharmacy practitioners will find a stepwise primer on identifying new po...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadah, Loai M, Deiab, Ghina’a I Abu, Al-Balas, Qosay A, Basheti, Iman A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891799/
https://www.ncbi.nlm.nih.gov/pubmed/36793906
http://dx.doi.org/10.18549/PharmPract.2022.4.2746
_version_ 1784881208254005248
author Saadah, Loai M
Deiab, Ghina’a I Abu
Al-Balas, Qosay A
Basheti, Iman A
author_facet Saadah, Loai M
Deiab, Ghina’a I Abu
Al-Balas, Qosay A
Basheti, Iman A
author_sort Saadah, Loai M
collection PubMed
description OBJECTIVE: Given the major shift to patient-directed education, novel coronavirus (nCoV) provides a live example on how medicinal chemistry could be a key science to teach pharmacy students. In this paper, students and clinical pharmacy practitioners will find a stepwise primer on identifying new potential nCoV treatments mechanistically modulated through angiotensin-converting enzyme 2 (ACE2). METHODS: First, we identified the maximum common pharmacophore between carnosine and melatonin as background ACE2 inhibitors. Second, we performed a similarity search to spot out structures containing the pharmacophore. Third, molinspiration bioactivity scoring enabled us to promote one of the newly identified molecules as the best next candidate for nCoV. Preliminary docking in SwissDock and visualization through University of California San Francisco (UCSF) chimera made it possible to qualify one of them for further detailed docking and experimental validation. RESULTS: Ingavirin had the best docking results with full fitness of −3347.15 kcal/mol and estimated ΔG of −8.53 kcal/mol compared with melatonin (−6.57 kcal/mol) and carnosine (−6.29 kcal/mol). UCSF chimera showed viral spike protein elements binding to ACE2 retained in the best ingavirin pose in SwissDock at 1.75 Angstroms. CONCLUSION: Ingavirin has a promising inhibitory potential to host (ACE2 and nCoV spike protein) recognition, and hence could offer the next best mitigating effect against the current coronavirus disease (COVID-19) pandemic.
format Online
Article
Text
id pubmed-9891799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-98917992023-02-14 Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model Saadah, Loai M Deiab, Ghina’a I Abu Al-Balas, Qosay A Basheti, Iman A Pharm Pract (Granada) Original Research OBJECTIVE: Given the major shift to patient-directed education, novel coronavirus (nCoV) provides a live example on how medicinal chemistry could be a key science to teach pharmacy students. In this paper, students and clinical pharmacy practitioners will find a stepwise primer on identifying new potential nCoV treatments mechanistically modulated through angiotensin-converting enzyme 2 (ACE2). METHODS: First, we identified the maximum common pharmacophore between carnosine and melatonin as background ACE2 inhibitors. Second, we performed a similarity search to spot out structures containing the pharmacophore. Third, molinspiration bioactivity scoring enabled us to promote one of the newly identified molecules as the best next candidate for nCoV. Preliminary docking in SwissDock and visualization through University of California San Francisco (UCSF) chimera made it possible to qualify one of them for further detailed docking and experimental validation. RESULTS: Ingavirin had the best docking results with full fitness of −3347.15 kcal/mol and estimated ΔG of −8.53 kcal/mol compared with melatonin (−6.57 kcal/mol) and carnosine (−6.29 kcal/mol). UCSF chimera showed viral spike protein elements binding to ACE2 retained in the best ingavirin pose in SwissDock at 1.75 Angstroms. CONCLUSION: Ingavirin has a promising inhibitory potential to host (ACE2 and nCoV spike protein) recognition, and hence could offer the next best mitigating effect against the current coronavirus disease (COVID-19) pandemic. Centro de Investigaciones y Publicaciones Farmaceuticas 2022 2022-11-08 /pmc/articles/PMC9891799/ /pubmed/36793906 http://dx.doi.org/10.18549/PharmPract.2022.4.2746 Text en Copyright: © Pharmacy Practice https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Saadah, Loai M
Deiab, Ghina’a I Abu
Al-Balas, Qosay A
Basheti, Iman A
Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model
title Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model
title_full Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model
title_fullStr Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model
title_full_unstemmed Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model
title_short Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model
title_sort computational medicinal chemistry role in clinical pharmacy education: ingavirin for coronavirus disease 2019 (covid-19) discovery model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891799/
https://www.ncbi.nlm.nih.gov/pubmed/36793906
http://dx.doi.org/10.18549/PharmPract.2022.4.2746
work_keys_str_mv AT saadahloaim computationalmedicinalchemistryroleinclinicalpharmacyeducationingavirinforcoronavirusdisease2019covid19discoverymodel
AT deiabghinaaiabu computationalmedicinalchemistryroleinclinicalpharmacyeducationingavirinforcoronavirusdisease2019covid19discoverymodel
AT albalasqosaya computationalmedicinalchemistryroleinclinicalpharmacyeducationingavirinforcoronavirusdisease2019covid19discoverymodel
AT bashetiimana computationalmedicinalchemistryroleinclinicalpharmacyeducationingavirinforcoronavirusdisease2019covid19discoverymodel